Melamud, B., Lurie, Y., Goldin, E., Levi, I. and Esayag, Y. (2014) Methylprednisolone-Induced Liver Injury: A Diagnostic Challenge. Israel Medical Association Journal, 16, 180-181.

has been cited by the following article:

• TITLE: Hepatotoxicity Induced by High Dose of Methylprednisolone Therapy in a Patient with Multiple Sclerosis: A Case Report and Brief Review of Literature

  AUTHORS: Mohamed A. H. Kadle, Natalia V. Mazurchik

  KEYWORDS: Toxic Hepatitis, Methylprednisolone, Multiple Sclerosis

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.6 No.5, May 23, 2016

  ABSTRACT: Toxic hepatitis due to drugs is an important and frequent drug adverse reaction in clinical practice. Here, we report a case of high dose methylprednisolone-induced acute hepatitis in a 51-year-old woman that suffers from multiple sclerosis while steroids are usually safe drugs with regards to liver injury and even they are the treatment choice of autoimmune hepatitis, but the literatures about corticosteroids showed are not entirely safe to liver injury and they have occasionally linked to hepatotoxicity. Although recent reports have demonstrated that prednisolone may cause hepatitis. This case report includes a brief review of the relevant literature on corticosteroids-induced hepatitis that is presented.